Politics

WHITE HOUSE PULLS HEIDI OVERTON'S FDA NOMINATION HOURS BEFORE KEY SENATE VOTE

Gary FranchiNovember 17, 2026 ET179 views
A key Senate committee vote on the FDA nomination is abruptly called off.
A key Senate committee vote on the FDA nomination is abruptly called off. | Next News Editorial Illustration
Advertisement

The White House on Tuesday pulled Dr. Heidi Overton's nomination to lead the Food and Drug Administration, a White House official confirmed, hours before a Senate committee was set to vote on her confirmation.

The move was first reported by Fox News. NBC News reported that Overton's path had narrowed in recent weeks as key Republicans on the Senate Health, Education, Labor and Pensions Committee raised doubts about her experience and her handling of vaccine policy questions. In the 21-member committee, Overton could have lost only one Republican vote if all Democrats opposed her.

President Donald Trump announced Overton's nomination in August, calling her a "ROCKSTAR." A preventive medicine physician who served as a domestic policy official in the White House, Overton was tapped to succeed Dr. Marty Makary, who resigned in May. Before joining the administration she was chief policy officer at the America First Policy Institute, a conservative think tank.

Cassidy's Doubts

Sen. Bill Cassidy, R-La., the committee chairman, publicly questioned whether Overton had the managerial experience to run an agency with roughly 18,000 employees and jurisdiction over vaccines, drugs, medical devices and the food supply. Before her September confirmation hearing, Cassidy wrote on X that he had "strong concerns" about the nomination. Last week he said he remained undecided.

At the hearing, Cassidy pressed Overton on her appearance alongside Trump in the Oval Office when the president signed an executive order calling for changes to childhood vaccine recommendations, including splitting the combined measles, mumps and rubella vaccine. "Yes, Senator, the MMR vaccine is safe and effective," Overton told him, according to Fox News. Asked what she would do if Trump directed her to disregard FDA safety standards, she said she would give the president her best advice and follow the legal requirements for reviewing individual products.

Sen. Lisa Murkowski, R-Alaska, declined last week to say how she would vote. During the hearing she asked Overton about political pressure surrounding access to mifepristone and criticized her for not taking a clear position.

Committee Math

With Democrats unified against the nomination, the committee arithmetic left no room for error. The withdrawal spares the White House a public defeat in a committee Republicans control and avoids forcing senators to cast a vote that would have been read as a rebuke of the president's health agenda.

Democrats on the panel had signaled opposition. Sen. Bernie Sanders, I-Vt., pressed Overton at the hearing to endorse universal health care as a human right, and Sen. Ed Markey, D-Mass., questioned why she had not corrected Trump in the Oval Office. Sen. Maggie Hassan, D-N.H., asked Overton directly whether the president was wrong on vaccines; Overton reiterated that the MMR vaccine is safe and effective and called it the best tool available during a measles outbreak.

Anti-abortion groups had their own demands. Erik Baptist, senior vice president for legal strategy at SBA Pro-Life America, said the group wants the next FDA nominee to commit to ending mail-order access to abortion drugs and to changing how the agency studies their safety before the Senate holds a confirmation vote. During the hearing, Murkowski questioned Overton on mifepristone access, and Overton declined to take a firm position.

The withdrawal was noted quickly online. The Gateway Pundit account on X posted that the White House pulled the nomination "after GOP Senators derailed her confirmation." The New York Times account posted breaking-news confirmation of the withdrawal ahead of the panel vote.

It is not yet known whom the White House will nominate to replace Overton, or whether the administration will leave the post filled on an acting basis while it searches. The FDA has been without a Senate-confirmed commissioner since Makary's resignation in May.

Our Take

This is a defeat for the president's health agenda, and it came from his own party. Overton was the rare nominee who had actually worked on the policies she would have overseen, and she answered the vaccine questions directly at her hearing. What sunk her was not a scandal or a gaffe. It was a handful of Republican senators who would rather avoid a floor fight than confirm a reformer.

But look at the timeline. The White House pulled the nomination before the vote, which means the administration counted the votes and chose to fight another day rather than lose on the record. That is a tactical retreat, not a surrender. The next nominee will face the same committee, the same math and the same pressure from the pro-life groups that wanted commitments on abortion pills.

The question for patriots is simple: if Senate Republicans will not confirm a qualified FDA pick who backs the president's vaccine review and refuses to rubber-stamp the abortion-drug status quo, what exactly will they confirm? The White House needs to find out before it sends another name to the Hill.

Advertisement
Advertisement
Gary Franchi
Gary Franchi

Chief White House Correspondent at Next News Network. Executive Producer and Lead Anchor.

Share this article:

Comments (4)

Leave a Comment

P
PatriotMom1972VerifiedNov 19, 5:38 PM ET
Of course they pulled it hours before the vote — they knew they didn't have the numbers and didn't want the embarrassment of a public defeat. This administration keeps playing games with these nominations instead of letting qualified people get a fair up-or-down vote.
L
LibertyRiderVerifiedNov 19, 11:38 PM ET
Exactly. Timing says everything here. If they had the votes, they'd have held the vote.
G
GrassrootsGusVerifiedNov 20, 1:38 AM ET
Or maybe they realized she had issues that would've sunk her anyway. Either way, the process looks bad.
R
RancherDaleVerifiedNov 19, 8:38 PM ET
I've watched FDA nominations come and go for thirty years, and I can't remember one getting yanked this late. Makes you wonder what came out in the last 24 hours that we aren't being told. Anyone know if there's a statement from Overton's team yet?